Osteolytic prostate cancer cells induce the expression of specific cytokines in bone-forming osteoblasts through a Stat3/5-dependent mechanism.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bone

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bone.2009.09.024PMID 19796718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumorigenesis and Neoplastic Progression Stat 3 Promotes Metastatic Progression of Prostate Cancer

  2010cited by this paper
• Paget's Disease of Bone: Histologic Analysis of 754 Patients

  2009cited by this paper
• The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice.

  2008cited by this paper
• Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases.

  2008cited by this paper
• CXCL5 promotes prostate cancer progression.

  2008cited by this paper
• Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.

  2008cited by this paper
• Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone

  2008cited by this paper
• Skeletal remodeling in health and disease

  2007cited by this paper
• PTHrP‐induced MCP‐1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro

  2007cited by this paper
• Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.

  2007cited by this paper
• Osteoporosis: trends in epidemiology, pathogenesis and treatment

  2006cited by this paper
• Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass

  2006cited by this paper
• Calcitonin Deficiency in Mice Progressively Results in High Bone Turnover

  2006cited by this paper
• SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation.

  2006cited by this paper
• Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases

  2006cited by this paper
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006cited by this paper
• Piceatannol attenuates lipopolysaccharide-induced NF-kappaB activation and NF-kappaB-related proinflammatory mediators in BV2 microglia.

  2006cited by this paper
• Piceatannol attenuates lipopolysaccharide-induced NF-κB activation and NF-κB-related proinflammatory mediators in BV2 microglia

  2006cited by this paper
• Prostate cancer cells promote osteoblastic bone metastases through Wnts.

  2005influential reference
• Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.

  2005cited by this paper
• Osteoblasts in prostate cancer metastasis to bone

  2005influential reference
• Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

  2005cited by this paper
• The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation

  2005cited by this paper
• Prostate cancer mediates osteoclastogenesis through two different pathways.

  2005cited by this paper
• A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse

  2005cited by this paper
• Prostate Carcinoma Skeletal Metastases: Cross-talk between Tumor and Bone

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases.

  2004cited by this paper
• The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells

  2004cited by this paper
• Drapc1 expression during mouse embryonic development.

  2004cited by this paper
• MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.

  2004cited by this paper
• Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

  2004cited by this paper
• The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

  2003cited by this paper
• Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.

  2003cited by this paper
• Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo

  2003cited by this paper
• Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway

  2002cited by this paper
• Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.

  2002cited by this paper
• Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities

  2002cited by this paper
• Establishment and characterization of osseous prostate cancer models: Intra‐tibial injection of human prostate cancer cells

  2002cited by this paper
• LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

  2001cited by this paper
• Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

  2001cited by this paper
• LDL-receptor-related protein 6 is a receptor for Dickkopf proteins

  2001cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.

  2001cited by this paper
• Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol.

  2000cited by this paper
• Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

  2000cited by this paper
• Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

  2000cited by this paper
• Erratum: Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord (Nature Medicine (2000) 6 (521-528))

  2000cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

  1998cited by this paper
• Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines

  1998cited by this paper
• Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

  1997cited by this paper
• Skeletal complications of malignancy

  1997cited by this paper
• Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate

  1995cited by this paper
• Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells

  1994cited by this paper
• Quantitative histology of myeloma‐induced bone changes

  1982cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• Edinburgh Research Explorer Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization

  year unknowncited by this paper

• Exosomal tumor necrosis factor‐α from hepatocellular cancer cells (Huh‐7) promote osteoclast differentiation

  2021cites this paper
• Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo

  2021cites this paper
• Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma

  2020cites this paper
• Title Sex differences of leukocytes DNA methylation adjusted for estimatedcellular proportions

  2017cites this paper
• Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases.

  2016cites this paper
• Matricellular proteins as regulators of cancer metastasis to bone.

  2016cites this paper
• Sex differences of leukocytes DNA methylation adjusted for estimated cellular proportions

  2015cites this paper
• The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer

  2014cites this paper
• Orexin expression in different prostate ’ s histopathologic conditions : should it be a marker for prostate cancer ? A preliminary result

  2014cites this paper
• Cavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation

  2014cites this paper
• The Multifaceted Roles of STAT 3 Signaling in the Progression of Prostate Cancer

  2014cites this paper
• Orexin expression in different prostate histopathologic examinations: Can it be a marker for prostate cancer? A preliminary result.

  2013cites this paper
• Orexin expression in different prostate histopathologic examinations: Can it be a marker for prostate cancer? A preliminary result Farkli prostat histopatolojilerinde oreksin varliği: Prostat kanserinde bir belirteç olabilir mi? Ön çalişma

  2013cites this paper
• Chronic Inflammation in Cancer Development

  2012cites this paper
• p65-Dependent production of interleukin-1β by osteolytic prostate cancer cells causes an induction of chemokine expression in osteoblasts.

  2012influential citation
• Slug contributes to the regulation of CXCL12 expression in human osteoblasts.

  2011cites this paper
• Interleukin‐33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells

  2011cites this paper
• Mammalian Neutral Sphingomyelinases: Regulation and Roles in Cell Signaling Responses

  2010cites this paper
• Die Rolle von Calcitonin und seines Rezeptors im Knochenstoffwechsel - Untersuchungen an gentechnisch modifizierten Mausmodellen

  2010cites this paper
• Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

  2010cites this paper